ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "fibromyalgia"

  • Abstract Number: 1653 • 2017 ACR/ARHP Annual Meeting

    Factors Influencing on Health-Related Quality of Life in Female Systemic Lupus Erythematosus Patients with Fibromyalgia

    Kyung Min Ko1, Jun-Ki Min2 and Su-Jin Moon3, 1Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South), 2Bucheon St. Mary's Hospital, Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Bucheon, Korea, Republic of (South), 3Bucheon St. Mary's Hospital, Division of rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Bucheon, Korea, Republic of (South)

    Background/Purpose: Health-related quality of life (HRQoL) among systemic lupus erythematosus (SLE) patients is reduced, and fibromyalgia contribute to the decreased HRQoL. The objective of the…
  • Abstract Number: 1868 • 2017 ACR/ARHP Annual Meeting

    Association between Brain-Derived Neurotrophic Factor Gene Polymorphisms and Fibromyalgia in a Korean Population: A Multi-Center Study

    Ji-Hyoun Kang1, Kyung-Eun Lee2, Dong-Jin Park1, Seong-Ho Kim3, Seong-Su Nah4, Ji Hyun Lee5, Seong-Kyu Kim6, Yeon-Ah Lee7, Seung-Jae Hong8, Hyun-Sook Kim9, Hye-Soon Lee10, Hyoun-Ah Kim11, Chung-Il Joung12, Sang-Hyon Kim13 and Shin-Seok Lee1, 1Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, Korea, Republic of (South), 2Chonnam National University Medical School and Hospital, Gwangju, Korea, Republic of (South), 3Inje University Haeundae Paik Hospital, Busan, Korea, Republic of (South), 4Soonchunhyang University, College of Medicine, Cheonan, Korea, Republic of (South), 5Maryknoll Medical Center, Busan, Korea, Republic of (South), 6Rheumatology, Catholic University of Daegu School of Medicine, Daegu, Korea, Republic of (South), 7Rheumatology, Kyung Hee University Hospital, Seoul, Korea, Republic of (South), 8Dept. of Rheumatology, #1 Hoeg, KyungHee University Medical Center, SEOUL, Korea, Republic of (South), 9Soonchenhyang university school of medicine, Seoul, Korea, Republic of (South), 10Hanyang University Guri Hospital, Gyeonggi-do, Korea, Republic of (South), 11Ajou University Hospital, Suwon, Korea, Republic of (South), 12Konyang University Medical School, Daejeon, Korea, Republic of (South), 13Division of Rheumatology, Department of Internal Medicine, Keimyung University Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Republic of Korea, Daegu, Korea, Republic of (South)

    Background/Purpose: Several lines of evidence suggest that brain-derived neurotrophic factor (BDNF) is involved in the pathophysiology of fibromyalgia (FM) and studies have found that FM…
  • Abstract Number: 1869 • 2017 ACR/ARHP Annual Meeting

    Effects of Add-on Transcranial Direct Current Stimulation on Pain in Korean Patients with Fibromyalgia

    Ji-Hyoun Kang1, Kyung-Eun Lee2, Dong-Jin Park1 and Shin-Seok Lee1, 1Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, Korea, Republic of (South), 2Chonnam National University Medical School and Hospital, Gwangju, Korea, Republic of (South)

    Background/Purpose: Despite promising preliminary results of transcranial direct current stimulation (tDCS) treatment in patients with fibromyalgia (FM), several issues need to be addressed, including its…
  • Abstract Number: 1872 • 2017 ACR/ARHP Annual Meeting

    The Effect of EEG-Amygdala-Related-Neurofeedback on REM Latency in Patients with Fibromyalgia

    Noam Goldwway1, Haggai Sharon1, Eti Ben Simon1, Libat Weizman1, Ayam Greental1, Omer Lubin1, Marc Cavazza2, Fred Charles3, Talma Hendler1 and Jacob N. Ablin4, 1Functional Brain Center, Wohl Institute for Advanced Imaging, Tel-Aviv Sourasky Medical Centre, Tel Aviv, Israel, 2School of Computing, Teesside University, United Kingdom, Middlesbrough, United Kingdom, 3Department of Creative Technology, Bournemouth University, Bournemouth, United Kingdom, 4Rheumatology, Rheumatology Institute, Tel Aviv, Tel Aviv, Israel

    Background/Purpose: Fibromyalgia syndrome (FMS) is a condition characterized by widespread pain, sleep disturbance and chronic fatigue, and mood disorder .FMS was suggested to represent a…
  • Abstract Number: 1873 • 2017 ACR/ARHP Annual Meeting

    Evaluating Pain Related Disability in Fibromyalgia: A Comparison of the Fibromyalgia Impact Questionnaire and the Polysymptomatic Distress Scale

    Nilamba Jhala1, Yaseen Kinanah2, Sahar Kaouk3, Deb Bork4, Sara Davin5, Sarah Rispinto5, William Wilke4 and Carmen E. Gota4, 1Internal Medicine, Cleveland Clinic, Cleveland, OH, 2Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, 3John Carroll University, University Heights, OH, 4Orthopedic and Rheumatologic Institute, Cleveland Clinic, Cleveland, OH, 5Neurologic Institute, Cleveland Clinic, Cleveland, OH

    Background/Purpose: Both the fibromyalgia impact questionnaire (FIQ) and the polysymptomatic distress scale (PSD) have been proposed as measures of FM impact and severity. It is…
  • Abstract Number: 1973 • 2017 ACR/ARHP Annual Meeting

    Fibromyalgia in Real Life a National French Web-Based Survey in 4516 Patients

    Francoise Laroche1, julien Guerin2, deborah Azoulay3, joel Coste4 and serge Perrot3, 1Pain and Palliative care, APHP Hospital, Paris, France, 2CETD, APHP Hospital, Paris, France, 3CETD, Paris, France, 4Biostatistics in university Hospital, Paris, France

    Background/Purpose: Fibromyalgia (FM) is the most frequent widespread chronic pain disorder (1,6% of the French population) (1). The medical and socioeconomic burden is high and…
  • Abstract Number: 1974 • 2017 ACR/ARHP Annual Meeting

    Efficacy and Safety of Pregabalin for Fibromyalgia in a Population of Chinese Patients: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial

    Xiao Zhang1, Huji Xu2, Zhiyi Zhang3, Yang Li4, Lynne Pauer5, Shanmei Liao6, Gaiping Xu7 and Fengchun Zhang8, 1Guangdong General Hospital, Guangdong, China, Guangdong, China, 2Department of Rheumatology and Immunology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China, 3The First Affiliated Hospital of Harbin Medical University, Harbin, China, Harbin, China, 4The Second Affiliated Hospital of Harbin Medical University, Harbin, China, Harbin, China, 5Pfizer, Groton, CT, USA, Groton, CT, 6Pfizer (China) Statistics Department, Global Innovative Pharma Business, Shanghai, China, Shanghai, China, 7Pfizer (China) Clinical Development, Global Innovative Pharma Business, Beijing, China, Beijing, China, 8Peking Union Medical College Hospital, Beijing, China

    Background/Purpose: Global trial data demonstrate the efficacy of pregabalin for the treatment of pain associated with fibromyalgia (FM), but there are currently no approved medical…
  • Abstract Number: 1976 • 2017 ACR/ARHP Annual Meeting

    High and Low Widespread Pain Index Fibromyalgia Patient Groups, Same, or Different?

    Sahar Kaouk1, Yaseen Kinanah2, Nilamba Jhala3, Deb Bork4, Sarah Rispinto5, Sara Davin5, William Wilke4 and Carmen E. Gota4,6, 1John Carroll University, University Heights, OH, 2Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, 3Internal Medicine, Cleveland Clinic, Cleveland, OH, 4Orthopedic and Rheumatologic Institute, Cleveland Clinic, Cleveland, OH, 5Neurologic Institute, Cleveland Clinic, Cleveland, OH, 6The Cleveland Clinic Rheum, The Cleveland Clinic Desk A50, Cleveland, OH

    Background/Purpose: The ACR 2010 preliminary criteria for fibromyalgia (FM) classifies patients in high WPI group, widespread pain index (WPI) ≥7, symptom severity scale (SS) ≥5,…
  • Abstract Number: 153 • 2017 ACR/ARHP Annual Meeting

    Prevalence of Fibromyalgia in Physician in Training; A Cross Sectional Study

    Sarah Alobud1, Nour Alsultan1, Abeer Alhazzani1, Yasmin Altymani1, Muneera Albugami1, Maha Omair2 and Mohammed Omair3, 1King Saud University, Riyadh, Saudi Arabia, 2Department of Statistics, College of Science, King Saud University, Riyadh, Saudi Arabia, 3Division of Rheumatology, Department of Medicine, King Saud University, Riyadh, Saudi Arabia

    Background/Purpose: Physicians in training (PIT) are at increased of developing pain sensitization syndromes due to stress and interrupted sleep. The prevalence of fibromyalgia (FM) in…
  • Abstract Number: 1981 • 2017 ACR/ARHP Annual Meeting

    The Etiology of Fibromyalgia May be Related to Increased Muscle Pressure

    Robert S. Katz1, Jessica L. Polyak2, Alexandra Katz Small3, Ben J Small4 and Frank Leavitt1, 1Rush University Medical Center, Chicago, IL, 2Rheumatology Associates S.C., Chicago, IL, 3University of Illinois College of Medicine, Chicago, IL, 4Rheumatology, University of Illinois at Chicago Medical School, Chicago, IL

    The Etiology of Fibromyalgia May be Related to Increased Muscle PressureBackground/Purpose:  The muscles are tender in fibromyalgia syndrome (FMS) patients, and the location of pain…
  • Abstract Number: 155 • 2017 ACR/ARHP Annual Meeting

    Xerostomia in Patients with Fibromyalgia

    Nicolas Lloves1, Anastasia Secco2, Virginia Durigan3, Santiago Scarafia2, Felix Romanini Sr.4 and Marta Mamani4, 1Rheumatology Department, Hospital Rivadavia, Buenos Aires, Argentina, 2Hospital Bernardino Rivadavia, CABA, Argentina, 3Reumatology, Hospital Bernardino Rivadavia, CABA, Argentina, 4Hospital Rivadavia, Buenos Aires, Argentina

    Background/Purpose: Fibromyalgia (FM) is a rheumatic disease characterized by diffuse, chronic musculoskeletal pain, of non-articular origin, which is evidenced by the palpation of painful points…
  • Abstract Number: 1990 • 2017 ACR/ARHP Annual Meeting

    Effectiveness and Durability of a Brief Multidisciplinary Treatment Program for Patients with Fibromyalgia

    Jessica Gehin1, Andy Abril2, Fernando Rivera3, Benjamin Wang4, Ronald Butendieck2, Florentina Berianu2, Kenneth Calamia2, Madeleine Allman1, Isabel Abril1 and Barbara Bruce1, 1Department of Psychiatry and Psychology, Mayo Clinic Florida, Jacksonville, FL, 2Division of Rheumatology, Mayo Clinic Florida, Jacksonville, FL, 3Division of Consultative and Diagnostic Medicine, Mayo Clinic Florida, Jacksonville, FL, 4Rheumatology, Mayo Clinic Florida, Jacksonville, FL

    Background/Purpose: Fibromyalgia (FM) effects upwards of 60 million adults in the US alone. The disability and psychological distress often observed in these patients has been…
  • Abstract Number: 158 • 2017 ACR/ARHP Annual Meeting

    Is Lu Eight-Brocades Exercise Beneficial for Patients with Fibromyalgia?

    Juan Jiao1, Irwin Jon Russell2, Wen Wang3, Ya-yun Zhao4, Rou-man Zhang4, Jing Wang4 and Quan Jiang5, 1Rheumatism Department, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China, 2Affiliated with Arthritis & Osteoporosis Center of South Texas, Medical Director, Fibromyalgia Research and Consulting, San Antonio, Texas, San Antonio, TX, 3JCW Education Consulting, Conway, AR, 4Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China, 5Rheumatology Department, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China

    Background/Purpose: Fibromyalgia is a chronic debilitating musculoskeletal pain syndrome that causes substantial physical and psychological impairments. With the release of the 2016 revised EULAR recommendations…
  • Abstract Number: 1991 • 2017 ACR/ARHP Annual Meeting

    Fibromyalgia in Russian Refugees: Translation and Validation of the Revised Symptom Impact Questionnaire

    Kim Jones1, Robert M. Bennett1, Ronald Friend2 and Neema Mohammad Nader2, 1Schools of Nursing and Medicine, Oregon Health & Science University, Portland, OR, 2School of Nursing, Oregon Health & Science University, Portland, OR

    Background/Purpose: The Revised Symptom Impact Questionnaire (SIQR) is an updated version of the Revised Fibromyalgia Impact Questionnaire (FIQR) that can be used in both fibromyalgia…
  • Abstract Number: 160 • 2017 ACR/ARHP Annual Meeting

    Fibromyalgia Screening Form in the Diagnosis of Concomitant Fibromyalgia

    Robert S. Katz1 and Jessica L. Polyak2, 1Rush University Medical Center, Chicago, IL, 2Rheumatology Associates S.C., Chicago, IL

    Background/Purpose: We have found that patients with a variety of rheumatic diseases who have concomitant fibromyalgia more frequently fail therapies for the underlying inflammatory rheumatic…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 25
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology